NSW (9739) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
3 Aug, 2026Executive summary
Net sales for the three months ended June 30, 2026, rose 4.4% year-over-year to ¥11,951 million, with operating profit down 1.6% to ¥850 million and profit attributable to owners of parent down 4.5% to ¥577 million.
Comprehensive income decreased 3.1% year-over-year to ¥581 million.
Financial highlights
Gross profit increased to ¥2,144 million from ¥2,075 million year-over-year.
Operating profit declined to ¥850 million from ¥863 million, and ordinary profit fell to ¥869 million from ¥896 million year-over-year.
Basic earnings per share decreased to ¥38.78 from ¥40.61 year-over-year.
Total assets decreased to ¥47,760 million as of June 30, 2026, from ¥49,289 million at March 31, 2026.
Net cash provided by operating activities was ¥2,351 million, while investing activities used ¥4,110 million and financing activities used ¥1,127 million.
Outlook and guidance
Full-year forecast for fiscal year ending March 31, 2027: net sales of ¥54,000 million (up 3.0% year-over-year), operating profit of ¥5,400 million (up 2.1%), ordinary profit of ¥5,450 million, and profit attributable to owners of parent of ¥3,750 million (up 1.1%).
Forecasted basic earnings per share for the full year is ¥251.69.
Annual dividend forecast is ¥125.00 per share, with a first quarter dividend of ¥60.00.
Latest events from NSW
- Net sales up 4.8% YoY, operating profit down 13.5%, dividend per share raised to ¥125.00.9739
Q4 202611 May 2026 - Sales grew, but profits fell on higher costs and one-time losses; lower profit forecast ahead.9739
Q3 20269 Feb 2026 - Sales rose, but profits fell on higher costs; full-year outlook projects lower earnings.9739
Q2 202610 Nov 2025 - Quarterly profits and comprehensive income rose, with moderate growth forecast for the full year.9739
Q1 20258 Sep 2025 - Sales and profit rose modestly, with strong capital and higher cash reserves.9739
Q2 20258 Sep 2025 - Sales and profits rose, with strong capital and cash; full-year profit to dip slightly.9739
Q3 20258 Sep 2025 - Profit fell despite stable sales, with lower EPS and a cautious outlook for next year.9739
Q4 20258 Sep 2025 - Sales rose 4.2% year-over-year, but profits and net income declined; outlook remains cautious.9739
Q1 20268 Sep 2025